MMP2 and colorectal carcinoma: Additionally, we found that co-expression of other CAF markers, MMP2, PDPN, and THY1, in CRC tissues was associated with upregulation of immune related pathways, meaning this co-expression pattern could potentially serve as a marker for patient response to immunotherapy.